The dose of betamethasone in prenatal to prevent respiratory distress syndrome is
The core concept here is the pharmacological use of corticosteroids in prenatal care. The key is knowing the correct dosage regimen. From what I remember, the typical regimen is 12 mg administered intramuscularly (IM) every 24 hours for two doses. This is usually given when there's a risk of preterm delivery between 24 to 34 weeks' gestation. The rationale is that corticosteroids promote surfactant production in the fetal lungs, which is crucial for preventing RDS.
Now, looking at the options, the correct answer should be 12 mg IM twice. The other options might include different dosages or routes. For example, a common mistake might be to use a higher dose or a different administration method. Let's break down the possible distractors:
Option A might be a lower dose, like 6 mg, which is insufficient. Option B could be 8 mg, which is also not the standard. Option C might be a higher dose, such as 24 mg, which isn't part of the protocol. Option D could involve oral administration, which isn't the route used for betamethasone in this context.
The clinical pearl here is that the regimen is two doses of 12 mg, 24 hours apart. It's important to note that this is different from dexamethasone, which might have a different dosing schedule. Also, the timing is critical—administration should occur at least 24 hours before delivery to allow for surfactant synthesis.
Putting it all together, the correct answer is 12 mg IM twice. The other options are incorrect for the reasons outlined. The key takeaway is the specific dosage and route for betamethasone in this scenario, which is a high-yield fact for exams like NEET PG or USMLE.
**Core Concept**
Betamethasone is a corticosteroid administered prenatally to accelerate fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome (RDS). The standard regimen involves a specific dosage and timing to maximize surfactant production in preterm infants.
**Why the Correct Answer is Right**
The recommended dose is **12 mg intramuscularly (IM) every 24 hours for two doses**. This regimen, initiated between 24–34 weeks' gestation, stimulates fetal type II pneumocyte synthesis of surfactant via glucocorticoid receptors, reducing alveolar collapse and RDS incidence. The IM route ensures adequate maternal-fetal transfer, and the 24-hour interval allows for optimal corticosteroid activity.
**Why Each Wrong Option is Incorrect**
**Option A:** A lower dose (24 mg) risk maternal iatrogenic hyperglycemia